Lawrence Marnett Archives
Sep. 10, 2015—Vanderbilt University welcomed 97 new doctoral students on Sept. 4 during the sixth annual “Simple Beginnings” ceremony in a Light Hall lecture room packed with family members and other well-wishers.
May. 7, 2015—A new faculty task force has been appointed to prioritize and refine the eight health-related initiatives in the Academic Strategic Plan and to inventory existing health-related interdisciplinary centers and institutes at Vanderbilt.
Mar. 24, 2015—Vanderbilt students, faculty and staff are invited to participate in town hall meetings to learn more about progress and provide input on key initiatives of the Academic Strategic Plan.
Dec. 2, 2014—Susan Lindquist, Ph.D., a pioneer in the field of protein folding at the Whitehead Institute for Biomedical Research in Cambridge, Massachusetts, is the recipient of the 2014 Vanderbilt Prize in Biomedical Science, Vanderbilt University officials announced this week.
Aug. 22, 2014—An international expert on slavery and emancipation during the 18th and 19th centuries was awarded the prestigious Earl Sutherland Prize for Achievement in Research during Vanderbilt University’s Fall Faculty Assembly.
May. 29, 2014—Lawrence J. “Larry” Marnett, Ph.D., the Mary Geddes Stahlman Professor of Cancer Research and University Professor of Biochemistry and Chemistry, has been named Vanderbilt University Medical Center’s next associate vice chancellor for Research and senior associate dean for Biomedical Sciences, effective Sept. 1.
Jan. 21, 2014—The Kay Yow Cancer Fund, in partnership with the Women’s Basketball Coaches Association and The V Foundation for Cancer Research, has awarded a $100,000 ovarian cancer research grant to the Vanderbilt-Ingram Cancer Center.
Aug. 5, 2013—Chemically modified inhibitors of the COX-2 enzyme relieve anxiety behaviors in mice by activating natural “endocannabinoids” without gastrointestinal side effects, Vanderbilt University scientists will report next week.
Mar. 19, 2012—The April program for My Health Chat will be the promising world of cancer drug discovery. Panelists will be Lawrence Marnett, director of the Vanderbilt Institute of Chemical Biology, and Stephen Fesik, director of drug discovery at Vanderbilt-Ingram Cancer Center. They will discuss and take questions regarding how information about the genetic drivers of cancer...